{"name":"Theolytics Limited","slug":"theolytics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNNUlIZ0JpQlJ4dTdEWjlzN3R1VDNMWGRSa09Fc0dNTk1OTHdVajhSSHZMRFgwN2hwNU5zZkMwdTRzaDRpQ2tZN2lWZFhMODlKeEJ5ZWtlNGZteDcxT2tSZ0l1UWREQ3hmWk9PdzdXUHRCOVNva19UN0ZWcU1IYmNDSl92U05PR1lHb245eGFWMUtBUkktUnVhQU5ndU1zbmlHVnR0YzVWeFQ1eDluT3c?oc=5","date":"2026-03-04","type":"trial","source":"PharmaTimes","summary":"Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study - PharmaTimes","headline":"Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}